USE OF A COMBINATION OF AN ATYPICAL ANTIPSYCHOTIC AND A SEROTONIN REUPTAKE INHIBITOR FOR TREATMENT OF PSYCHOSIS
The invention provides pharmaceutical compositions which comprise a first component which is an atypical anti-psychotic in combination with a second component which is a serotonin reuptake inhibitor, use of such compositions for treating a patient suffering from or susceptible to psychosis, acute ma...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
18.11.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides pharmaceutical compositions which comprise a first component which is an atypical anti-psychotic in combination with a second component which is a serotonin reuptake inhibitor, use of such compositions for treating a patient suffering from or susceptible to psychosis, acute mania, mild anxiety states, or depression in combination with psychotic episodes, and particularly such compositions which comprise a first component which is olanzapine and a second component which is fluoxetine hydrochloride. |
---|---|
Bibliography: | Application Number: CA19972264941 |